Document:

exhibit103salariusscottj

       AMENDMENT TO SECOND AMENDED AND RESTATED EXECUTIVE                           EMPLOYMENT AGREEMENT                                                   THIS AMENDMENT TO THE SECOND AMENDED AND RESTATED EXECUTIVE   EMPLOYMENT AGREEMENT (this “Amendment”) is entered into effective as of September   10th,  2019  (the  “Effective  Date”),  by  and  among  Salarius  Pharmaceuticals,  LLC,  a  Delaware  limited  liability  company  (the  “Private  Salarius”),  Salarius  Pharmaceuticals,  Inc.  (f/k/a  Flex   Pharma, Inc.), a Delaware corporation (the “Company”), and Scott Jordan (the “Executive”), an   individual residing at the address set forth on the signature page below.                                             RECITALS          WHEREAS,  Private  Salarius  and  the  Executive  previously  entered  into  a Second   Amended and Restated Executive Employment Agreement on February 6, 2019 and effective as   of December 15, 2018 (the “Second Amended and Restated Agreement”);          WHEREAS, Section 13 of the Second Amended and Restated Agreement provides that   the Second Amended and Restated Agreement shall be binding on and inure to the benefit of   Private Salarius and its successors and assigns, and Private Salarius desires to assign the Second   Amended and Restated Agreement to the Company;          WHEREAS,   Section 16 of the Second Amended and Restated Agreement permits the   parties to amend or modify its terms by a mutually executed writing; and          WHEREAS, the parties desire to amend the Second Amended and Restated Agreement as   set forth herein.          NOW, THEREFORE, the parties agree as follows:          1.    Effective as of the Effective Date, Section 1 of the Second Amended and Restated   Agreement is amended by replacing the words “Chief Financial Officer” with the words “Chief   Business Officer.”          2.    Effective as of the Effective Date, Section 2 of the Second Amended and Restated   Agreement is amended and restated in its entirety as follows:                  “Duties.  The Executive shall faithfully perform all duties of the Company related to the         position or positions held by the Executive, including, but not limited to, strategic planning,         management  of  investments  (,  investors  and  foundations),  preparation  of  business  and         marketing plans, raising funds, operational oversight of consultants and employees, and         such  other  duties  as  are  typical  of  the  Chief  Business  Officer of  a  similarly  situated         company and such other duties as are prescribed from time to time by the Chief Executive         Officer of the Company.  Specifically, the Executive’s duties for the Company shall include         the following:                  (a)   working as a representative of Company on one or more steering committees which               may be established in connection with development alliances with third parties to                                          1                                                                                   

 

            assist the steering committees to perform their duties under applicable development              agreements;                                                                                        (b)   Oversee  strategic  and  business  development  initiatives,  public relations,              communications and contribute to  capital markets activities; and          (c)   identifying individuals who might be suitable to provide services for Company as              an employee, consultant or collaborator.                The  Executive  shall  be  a  full-time  and  an  exempt  at-will  employee  and  will  devote        approximately 40 hours of services per week, with the understanding that Executive will        work  such  hours  as  are  necessary  to  accomplish  the  specified  goals  and  objectives,  in        furtherance of the Company’s best interests.  The Executive shall comply with all Company        policies,  standards,  rules  and  regulations  (the  “Company  Policies”) and  all  applicable        government laws, rules and regulations that are now or hereafter in effect.  The Executive        acknowledges receipt of copies of all written Company Policies that are in effect as of the        date of this Agreement.”               3.     Effective as of July 19, 2019, (a) Private Salarius assigns its rights and obligations  under the Second Amended and Restated Agreement to the Company, and the Company accepts  such assignment and (b) each reference to the “Company” in the Second Amended and Restated  Agreement shall refer to the Company.        4.     Except  to  the  extent  amended  hereby,  the  Second  Amended  and  Restated  Agreement, and all of its terms and provisions, are hereby ratified and confirmed in all respects,  and shall remain in full force and effect.        5.     This Amendment may be executed in any number of counterparts, by facsimile if  necessary,  each  of  which  shall be  an  original,  but  all  of  which  together  shall  constitute  one  instrument.                               [Signature Page Follows]                                                                                    2                                                                                  

 

IN WITNESS WHEREOF, the undersigned have executed this Amendment to be effective as of  the Effective Date.                                          PRIVATE SALARIUS:                                                                            SALARIUS PHARMACEUTICALS, LLC                                                                                                                                                        By:   /s/ David J. Arthur                                             David J. Arthur                                            Chief Executive Officer                                                                                                                  COMPANY:                                        SALARIUS PHARMACEUTICALS, INC.                                                                                                                                                        By:   /s/ David J. Arthur                                             David J. Arthur                                            Chief Executive Officer                                                                            Company Address:                                                                            2450 Holcombe Blvd. East                                       Suite J-608                                      Houston, Texas 77021                                                                                                                  EXECUTIVE:                                                                                                                   /s/ Scott Jordan                                              Scott Jordan                                                                            Address:                                          3exhibit105salariusdavidj

                  AMENDMENT TO AMENDED AND RESTATED                      EXECUTIVE EMPLOYMENT AGREEMENT                                                   THIS  AMENDMENT  TO  THE  AMENDED  AND  RESTATED  EXECUTIVE   EMPLOYMENT AGREEMENT (this “Amendment”) is entered into effective as of September   10th,  2019  (the  “Effective  Date”),  by  and  among  Salarius  Pharmaceuticals,  LLC,  a  Delaware  limited  liability  company  (the  “Private  Salarius”),  Salarius  Pharmaceuticals,  Inc.  (f/k/a  Flex   Pharma, Inc.), a Delaware corporation (the “Company”), and David J. Arthur (the “Executive”),   an individual residing at the address set forth on the signature page below.                                             RECITALS          WHEREAS, Private Salarius and the Executive previously entered into an Amended and   Restated Executive Employment Agreement on February 5, 2019 and effective as of December   15, 2018 (the “Amended and Restated Agreement”);          WHEREAS,   Section  14  of  the  Amended  and  Restated  Agreement  provides  that the   Amended and Restated Agreement shall be binding on and inure to the benefit of Private Salarius   and its successors and assigns, and Private Salarius desires to assign the Amended and Restated   Agreement to the Company;          WHEREAS, Section 17 of the Amended and Restated Agreement permits the parties to   amend or modify its terms by a mutually executed writing; and          WHEREAS, the parties desire to amend the Amended and Restated Agreement as set forth  herein.         NOW, THEREFORE, the parties agree as follows:         1.     Effective as of July 19, 2019, (a) Private Salarius assigns its rights and obligations   under the Amended and Restated Agreement to the Company, and the Company accepts such   assignment and (b) each reference to the “Company” in the Amended and Restated Agreement   shall refer to the Company.         2.     Except to the extent amended hereby, the Amended and Restated Agreement, and   all of its terms and provisions, are hereby ratified and confirmed in all respects, and shall remain   in full force and effect.         3.     This Amendment may be executed in any number of counterparts, by facsimile if   necessary,  each  of  which  shall be  an  original,  but  all  of  which  together  shall  constitute  one   instrument.                                [Signature Page Follows]                                                                                      1                                                                                   

 

IN WITNESS WHEREOF, the undersigned have executed this Amendment to be effective as of  the Effective Date.                                       PRIVATE SALARIUS:                                                                            SALARIUS PHARMACEUTICALS, LLC                                                                                                                                                        By:   /s/ David J. Arthur                                             David J. Arthur                                            Chief Executive Officer                                                                                                                  COMPANY:                                        SALARIUS PHARMACEUTICALS, INC.                                                                                                                                                        By:   /s/ David J. Arthur                                             David J. Arthur                                            Chief Executive Officer                                                                            Company Address:                                              2450 Holcombe Blvd. East                                       Suite J-608        Houston, Texas 77021                                                                                                                  EXECUTIVE:                                                                                                                   /s/ David J. Arthur                                           David J. Arthur                                                                            Address:                                          2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00300-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00300-of-00352.parquet"}]]